Drug · DIN 02230366
CLONAPAM
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since March 10, 2021; first marketed January 31, 1997.
- Drug Identification Number (DIN)
- 02230366
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Targeted substances (CDSA IV)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Clonazepam N03AE01
- Class
- Human
- Record last updated
- September 24, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLONAZEPAM | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 10, 2021: NOC 25414Abbreviated New Drug Submission (ANDS) · Change in product ownership
- April 25, 2005: NOC 6622Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- December 24, 1996: NOC 4268Abbreviated New Drug Submission (ANDS)
Other DINs named CLONAPAM
- DIN 02230368 · Dormant
- DIN 02230369 · Dormant